ESRA19-0475 Chronic pain neuromodulation for the anaesthesiologist not in practice, but why not in the future

2019 ◽  
Author(s):  
C Aksu ◽  
Y Gürkan
Keyword(s):  
Chronic Pain ◽  
The Future

scholarly journals The Future of Yoga Therapy and the Role of Standardization

2007 ◽  
Vol 17 (1) ◽  
pp. 15-18
Author(s):  
Ginger Garner
Keyword(s):  
Chronic Pain ◽  
Physical Therapy ◽  
Therapist Training ◽  
Yoga Therapy ◽  
The Public ◽  
The Future ◽  
Orthopedic Injuries ◽  
Positive Step ◽  
The U.S

Thanks to IAYT, Yoga therapists have a forum where we can find one another, collaborate, research, educate the public, and have a professional association to call home. IAYT's mission is to establish Yoga as a recognized and respected therapy. I fully support and believe in IAYT's mission. I am a practitioner of Yoga therapy, combining physical therapy, Yoga, and Ayurveda to specialize in women's health, chronic pain, and orthopedic injuries, and am the founder and director of a Yoga therapist training program. Having wellfamiliarized myself with the definitions of Yoga therapy from each of the current Yoga therapy programs in the U.S., and having followed the discussions about standards in Yoga therapy on the Integrator Blog (theintegratorblog.com) and in IAYT's publications, I humbly offer what I believe would be a positive step in the future of the recognition of Yoga therapy as a healing therapeutic discipline in the U.S.

The Psychology of Opioid Tapering

2021 ◽  
pp. 231-250
Author(s):  
Daniel M. Doleys ◽  
Nicholas D. Doleys
Keyword(s):  
Chronic Pain ◽  
Physical System ◽  
Evidence Based ◽  
Double Pendulum ◽  
The Future ◽  
Opioid Tapering ◽  
The Individual ◽  
Evidence Based Guidelines ◽  
Existing Data ◽  
The Way

The pendulum has swung; in this case, it may be a double pendulum. The double pendulum is a pendulum hanging from a pendulum. It is a simple physical system used in physics to demonstrate mathematical chaos. When the motion of its tip is monitored, it appears very predictable at the outset, but soon reveals a very chaotic and unpredictable pattern. It is very difficult to know where the tip of the double pendulum will be at any given time in the future. This seems to describe the course of the use of opioids, especially for the treatment of chronic pain. Once, all but ignored, then heralded, and then demonized. At every step of the way, pundits will argue the incompleteness, absence, or misinterpretation of existing data. It is important to understand the psychological environment is which the opioid tapering movement occurs and to carefully consider the process in the context of the individual patient. Simply instituting another set of presumptive evidence-based guidelines could have unforeseen, and potentially tragic, consequences for the patient.

Longitudinal trial of a smartphone pain application for chronic pain patients: Predictors of compliance and satisfaction

2016 ◽  
Vol 24 (2) ◽  
pp. 93-100 ◽  
Author(s):  
Robert N Jamison ◽  
Anna Mei ◽  
Edgar L Ross
Keyword(s):  
Chronic Pain ◽  
Future Development ◽  
Activity Monitor ◽  
Safety And Efficacy ◽  
Safety Issues ◽  
Frequent Use ◽  
Chronic Pain Patients ◽  
The Future ◽  
Pain Patients ◽  
Positive Effect

Introduction This study was designed to determine the feasibility, tolerability, safety and efficacy of a smartphone pain application (app) among chronic pain patients over a six-month trial. The app was designed for both Android and iPhone devices and enabled users with chronic pain to assess, monitor, and communicate their status to their providers. Methods We recruited 90 chronic pain patients to use the pain app. All subjects completed baseline measures and were asked to record their progress every day. All participants were supplied an activity monitor. Results Average age of the participants was 46.7 years (range 18–79), 64.4% were female and 31.1% reported multiple pain sites. Satisfaction was rated at three and six months. The app was found to be easily introduced and well tolerated. In general, those who used the app more often were more satisfied with the program ( p < 0.05), although satisfaction ratings of the pain app diminished with time. Greater use of the app and frequent daily assessment entries were found to be related to an overall improvement in mood. However, contrary to our hypotheses, frequent use of the app did not have a positive effect on pain or activity. Those who were more satisfied with the app reported more pain-related disability and were less active than those who were less satisfied with the app. No safety issues were encountered. Discussion Strategies to make the program more engaging and to improve motivation to use the app would be important in the future development and use of a smartphone pain app.

scholarly journals Effectiveness of pain education to improve pain related knowledge, attitudes and behaviours in health care students and professionals: a systematic review protocol

2019 ◽  
Vol 26 (8) ◽  
pp. 1-8
Author(s):  
Jagjit Mankelow ◽  
Cormac Ryan ◽  
Paul Taylor ◽  
Dominic Simpson ◽  
Denis Martin
Keyword(s):  
Systematic Review ◽  
Health Care ◽  
Chronic Pain ◽  
Health Care Professionals ◽  
Attitudes And Beliefs ◽  
Pain Education ◽  
Health Care Students ◽  
The Future ◽  
Review Protocol ◽  
Randomised Controlled

Background/Aims Chronic pain is a long-term condition and a leading cause of disability worldwide. The training of health care professionals is where knowledge and attitudes about pain may be shaped for the future. Pain education and management by health care professionals is recognised as being inadequate. This systematic review investigates the effectiveness of biopsychosocial education in improving health care professionals' and students' management of chronic pain. It informs the future delivery of effective pain management education. Methods Biopsychosocial education randomised controlled trials involving health care professionals or students, and measuring changes in knowledge or understanding, attitudes and beliefs or management behaviours in pain, will be included. Comparison studies will feature usual education control, placebo, or a different type of education. Two reviewers will apply two screenings and assess for bias. Statistical analysis of data will be undertaken or discussed in narrative and graphic format if necessary.

Understanding and managing pain in the arthritic synovial joint: an update

2022 ◽  
Vol 27 (1) ◽  
pp. 1-5
Author(s):  
John Innes
Keyword(s):  
Chronic Pain ◽  
Joint Pain ◽  
Synovial Joint ◽  
Common Cause ◽  
New Targets ◽  
Great Progress ◽  
The Future ◽  
Arthritic Joints ◽  
Insight Into ◽  
Made In

Osteoarthritis is a very common cause of chronic pain in dogs and cats. Great progress has been made in the last 2–3 decades in unravelling the molecular mediators of joint pain. Now we are starting to see the benefits of this research in terms of new targets to block joint pain and new medicines reaching our pharmacy shelves. This review summarises the progress that has been made in understanding why and how arthritic joints cause pain. This will help readers understand novel medicines and provide insight into the others that might follow in the future.

scholarly journals Development of research priorities in paediatric pain and palliative care

2016 ◽  
Vol 11 (1) ◽  
pp. 9-15 ◽  
Author(s):  
Christina Liossi ◽  
Anna-Karenia Anderson ◽  
Richard F Howard ◽  
Keyword(s):  
Chronic Pain ◽  
Palliative Care ◽  
Priority Setting ◽  
Research Priorities ◽  
Healthcare Research ◽  
Nominal Group ◽  
Research Network ◽  
Future Research ◽  
Wide Range ◽  
The Future

Priority setting for healthcare research is as important as conducting the research itself because rigorous and systematic processes of priority setting can make an important contribution to the quality of research. This project aimed to prioritise clinical therapeutic uncertainties in paediatric pain and palliative care in order to encourage and inform the future research agenda and raise the profile of paediatric pain and palliative care in the United Kingdom. Clinical therapeutic uncertainties were identified and transformed into patient, intervention, comparison and outcome (PICO) format and prioritised using a modified Nominal Group Technique. Members of the Clinical Studies Group in Pain and Palliative Care within National Institute for Health Research (NIHR) Clinical Research Network (CRN)-Children took part in the prioritisation exercise. There were 11 clinically active professionals spanning across a wide range of paediatric disciplines and one parent representative. The top three research priorities related to establishing the safety and efficacy of (1) gabapentin in the management of chronic pain with neuropathic characteristics, (2) intravenous non-steroidal anti-inflammatory drugs in the management of post-operative pain in pre-schoolers and (3) different opioid formulations in the management of acute pain in children while at home. Questions about the long-term effect of psychological interventions in the management of chronic pain and various pharmacological interventions to improve pain and symptom management in palliative care were among the ‘top 10’ priorities. The results of prioritisation were included in the UK Database of Uncertainties about the Effects of Treatments (DUETS) database. Increased awareness of priorities and priority-setting processes should encourage clinicians and other stakeholders to engage in such exercises in the future.

scholarly journals COVID-19 Pandemic: Implications on Interventional Pain Practice—a Narrative Review

2020 ◽  
Vol 4S;23 (8;4S) ◽  
pp. S311-S318
Author(s):  
Sudhir Diwan
Keyword(s):  
Chronic Pain ◽  
Immune System ◽  
Pain Management ◽  
Personalized Medicine ◽  
Regenerative Medicine ◽  
Key Words ◽  
Normal Saline ◽  
Local Anesthetics ◽  
The Future ◽  
Interventional Pain Management

Background: The COVID-19 pandemic has emerged and has challenged us to look for alternatives to bring about a paradigm shift in interventional chronic pain management. As the disease lowers the body’s immune system, the use of medications that suppress the immune system are not recommended during the COVID-19 pandemic. Objective: The purpose of this study was to review medications other than steroids used for interventional pain management and the emphasis on mitigation of the untoward consequences of steroid injections on the immune system during the COVID-19 pandemic. Literature Search: The literature was searched for articles in English with key words COVID-19, immunity, steroid for pain management injections with steroid, local anesthetics, dextrose water, normal saline, pain and genetic medicine, pain, and regenerative medicine. The sources of articles were PubMed, Embase, and open Google search. Literature Review: The medications used for interventional pain management include steroids and opioids. The side effects of these medications are well known but have never been looked at as critically as they are now. Many other medications have been used for interventional pain procedures to relieve pain, such as dextrose water, normal saline solution, local anesthetics, and many adjuvants. Regarding regenerative therapy, despite plenty of evidence in literature, we have not yet considered it as a routine therapy for chronic pain injections. It is now time to move on beyond steroids and consider other types of medications and treatment options. The use of these medications in clinical practice is less auspicious, and thus more research is needed on the practical applications. Further areas for research include studies to determine definitive efficacy and safety assessment and determine whether or not the analgesic effects of these drugs are duration or dose-dependent. The optimal identification of candidates, volume, concentration, and intervals of injection are essential for routine application in interventional chronic pain practice. Conclusions: The future of interventional pain practice is trending toward regenerative medicine and genetic research. Numerous scientific studies have been conducted to investigate the genetic basis of phenotypic variability in individuals with different ethnic groups in terms of susceptibility to chronic pain, as well as response to treatment for the personalized medicine model. Despite the preliminary data on genetic variations, there is no evidence for the use of a pharmacogenomicsbased approach to personalized medicine for patients with chronic pain. The field of medicine therefore needs further research in pharmacogenetics, including large-scale prospective studies that focus on pain pathways. However, recent research, including larger studies and larger-scale genomic perspectives, may yield more promising findings in the future. The COVID-19 pandemic proved the need for medications with the most impact and least complications. Key words: COVID-19, steroid, pain injections, chronic pain, immune system, regenerative medicine

scholarly journals Mandatory pharmacist-led education session for patients seeking medical cannabis

2020 ◽  
Vol 18 (4) ◽  
pp. 2088
Author(s):  
Vikas Parihar ◽  
Laura Katz ◽  
Mahmoud A. Siyam ◽  
Anna Rogers ◽  
Lisa Patterson ◽  
...  
Keyword(s):  
Chronic Pain ◽  
Perceived Benefits ◽  
Medical Cannabis ◽  
Education Session ◽  
Chi Square ◽  
Mandatory Education ◽  
Chronic Pain Patients ◽  
The Future ◽  
The Impact ◽  
Pain Patients

Objective: The primary objectives of this pre-post session study, was to evaluate the impact of a pharmacist-led education session on the perceived benefits and safety of cannabis among patients with chronic pain, as well as determine the influence of pharmacist education on the selection of safer cannabis products and dosage forms for medical use among patients. Methods: A retrospective analysis of completed pre-post session questionnaires was conducted among chronic pain patients attending a mandatory education session led by a pharmacist, prior to being authorized cannabis in clinic. All questionnaire data was analyzed using SPSS v. 25. Demographic and sample characteristics were reviewed using univariate analyses. Chi-Square tests were employed to determine if the group-based education significantly affected knowledge, perception of efficacy and safety of cannabis. Results: Of the 260 session participants, 203 completed pre-post session questionnaires. After the session, a majority of current cannabis users (33.8%) and cannabis naïve/past users (56.9%) reported they would use a low THC product in the future, and a majority of current users (54.5%) would use a high CBD product in the future. After education, participants were more likely to report cannabis as having the potential for addiction (chi-square =42.6, p <0.0001) and harm (chi-square =34.0, p <0.0001). Conclusions: Pharmacist counselling and education has the potential to influence patient selection and use of cannabis, from more harmful to safer products, as well as moderate the potential perceived benefits of use.

Sign in / Sign up

Export Citation Format

Share Document